IRS
IART icon

Invictus RG (Singapore)’s Integra LifeSciences IART Stock Holding History

Invictus RG (Singapore)’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-366
Closed -$11K – 201
2015
Q3 		$11K Buy
+366
New +$11.4K 0.01% 544

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

Invictus RG (Singapore)'s IART Position: Q4 2015 in Review

Invictus RG (Singapore) sold out of Integra LifeSciences (IART) in Q4 2015, closing a stake of 366 shares — an estimated $11K sold.

Invictus RG (Singapore) first reported a position in IART in Q3 2015 and held it in 1 quarter. The position peaked at $11K in Q3 2015. 187 funds tracked by Wall St. Rank hold IART as of Q4 2015.

  • Invictus RG (Singapore) reported no remaining Integra LifeSciences position as of Q4 2015 after selling out during the quarter.
  • Invictus RG (Singapore) sold 366 Integra LifeSciences shares in Q4 2015, an estimated $11K.
  • Invictus RG (Singapore) first reported a position in Integra LifeSciences in Q3 2015 and held it in 1 quarter.
  • Invictus RG (Singapore)'s Integra LifeSciences position peaked at $11K in Q3 2015.
  • 187 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2015.

Based on Invictus RG (Singapore)'s 13F filing for Q4 2015.